HHCTHTYTA 3A MYJITwkICqkIIIJIkIHAPHA kICTPAXkIBABA E E O r P m

O~JIYKOM HapHor ~ e h a I/IHCTMTYT~ 38 MyJITkInkICqUIIJIUHapHa kICTpalKkIBaKa n o ~ e ~ o j Ha CenHuqu onpxa~oj 17.1 1.20 10. ronuae uMeHosaHa je Ko~ucuja 3a y~spljusafie ucnyKeaocTu ycnosa np cq Men C a ~ e Apaua, cnequjanuc~e G u 3 u ~ a n ~ e MenuquHe u pexa6unu~aquje sanocne~e y K ~ H H H ~ M 3a pexa6unu~aqkijy ((Ap Mupocnas ~ O T O B M ~ ) ) Y Eeorpany, 3a ~ 3 6 0 ~ y HayHOkICTPaXHBaYKO 3BaKe H a Y g H U C a p a A H U K , o6nac~ HeypoHayKe.

Ko~ucuja je a~anu3upma npujasy KaHnunaTa np cu Men Cabe B a v a , u Ha OCHOBY IIpkiJIOXeHe n0KyMeHTaqkIje nOnHOCkI H~YYHOM sehy ~JIenehki

Ap C a ~ a Apava je poljesa y Tysnu 14.7.1962. ron., rne je saspmuna OCHOBHY H

cpenKy meony. M e n u q u ~ c ~ u G a ~ y n ~ e ~ y Eeorpany ynucma je 1981. ron. u AunnoMupana j y ~ a 1987. ron. ca npocevHoM oqeaoM 9,25, u TuMe cTema 3 s a ~ e nonopa MenuquHe. TOKOM c~ynuja 1986. ron. npeKo ~ e l j y ~ a p o n ~ e p a 3 ~ e ~ e je 6una Ha C T ~ Y Y H O M ycaspmasaKy y rpauy, Aycquja. 06asuna je 06ase3a~ neKapcKu cTax H

nonoxuna C T ~ ~ H H kicnkiT 1988.ron. On 1989. no 1990. ron. je panuna Kao BonoHTep HCTpaXkiBav y ~ I M Y H O ~ O ~ U K O ~ na6opa~opuju Y H ~ I B ~ ~ ~ ~ I T ~ T C K ~ nevllje KnkIHkiKe Y Eeorpany, a on 1990. no 1991. ron. Kao capanHuK y ICN- r a n e ~ u ~ a Pharmaceuticals. HapenHe 3 ronuHe (199 1 .-1994.) je sanocne~a Ha onpeljeao speMe Kao ucTpmusav y Onef ie~y 3a KnuHuvKy u eKcnepuMeHTanHy o ~ ~ o n o r u j y M H C T ~ T Y T ~ 3a o ~ ~ o n o r u j y u panuonorujy y Eeorpany. On 1994. no 1998. ron. je panuna Kao BonoHTep, a noToM u Kao w r u ~ u v ~ u neKap Ha ~IHCTUTYT 38 Heyponorujy KJI~IHHYKo~ qeH.rpa Cp6uje. On 2000. ron. je sanocne~a Kao KnuHuvKu neKap a noToM u Kao neKap cnequjmuc~a Ha onefieby ~eypopexa6unu~asuje K ~ H H H K ~ 3a pexa6unu~aqujy ((ap M.30~0sui)) y Eeorpany.

Cnequjanuc~uv~u ucnm u3 G u 3 u ~ m ~ e Menusme H pexa6anu~aquje je nonoxuna y jyny 2003. ron. ca onnuvHuM ycnexoM.

r o n u ~ e 2006. je ynucana AoKTopcKe c~ynuje, cMep HeypoHayKe, Ha M ~ ~ H ~ H H c K o M G a ~ y n ~ e ~ y y Kparyjesqy. Y jyny 2010. ron. je ca ycnexoM on6pa~una ~OKTOPCKY n~cep~auu jy Ha TeMy ((IIon~a cnequGuvaoc~ H qepe6pan~a a c k ~ ~ e q k ~ j a Kao G a m p u onopasKa n a q u j e ~ a ~ a nocne qepe6posac~ynap~or ~ ~ 3 y n ~ a ) ) .

Ap C a ~ a Apava je 06jasuna 28 panosa, ymyvyjyhu u ~OKTOPCKY nucep~auujy. On HaseneHux panosa, 11 panosa je ~ ~ ~ J I M K O B ~ H O y UenuHu, on Tora 8 panosa je n y 6 n u ~ o s a ~ o y ~ e l j y ~ a p o n ~ u ~ YaconucuMa UHneKcupaHuM y Science Citation Index- y. Panosu cy UuTupaHu 49 nyTa y ~ e l j y ~ a p o n ~ u ~ vaconucma. a p C a ~ a apava je AO~I.ITHUK BkIUIe ~TkineHnklja O n CTpaHe Opra~Ll3a~ki0Hki~ KOMkITeTa M ~ ~ ) ~ H ~ P O ~ H ~ I X

cKynosa panu yserrrha u npe3e~~aukije panosa. On 2006. ron. je snaH yperjkisas~or o~6opa saconkica ((International Journal of Biomedical Science)), n y 6 n u ~ o s a ~ o r y C j e ~ u % e ~ m A M ~ P H ~ K H M Apxasa~a , I . I _ ~ ~ I J ~ H ~ ~ H T saconuca "Indian Journal ofMedical Sciences", ny6nu~osa~or y EI~nujki.

Y n a ~ je Cpnc~or neKapcKor ApyrrrTsa, Apym~sa 3a HeypoHayrce CpGuje, The European Federation of Neurological Societies, J I e ~ a p c ~ e KoMope Cp6kije.

1. DraEa S. Prolactin as an immunoreactive agent (Review). Immunol Cell Biol 1995; 73: 481- 483. (1998: l3~narc.r aalc~op 1,905, lca~eropuja 661139, HenocTynHa lca~eropusaquja 1993-1995)

1. DraEa S. The participation of natural cytotoxicity in the control of malignant disease. (Review) Panminerva Med 1993; 35: 123-6. (1992: & ~ M I I ~ I C T Oalc~op 0,065, lca~eropuja 951116)

2. DraEa S. Possible role and mechanism of inactivation of decidual NK cells in pregnancy. (Review) Med Hypotheses 1994; 43: 418-9. (1992: M ~ n a r c ~ aalc~op 0,442, rca~eropuja 35148)

3. DraEa S., ierjav S., RadivojeviC M. The analysis of virus-caused alterations of cellular and humoral immunoresponsiveness during the first days of morbilli rush in young adult population. Acta Virol 1994; 38:199-204. (1992 : M ~ n a l c ~ Oalc~op 0,275, lca~eropn ja 14115, HenocTynHa lca~eropusaquja 1993-1995).

4. DraEa S. Endocrine-immunological homeostasis: the interrelationship between the immune system and sex steroids involves the hypotalamic-pituitary-gonadal axis. (Review) Panminerva Med 1995; 37(2): 71-6. (1998: MMII~KT Oalc~op 0,213, lca~eropmja 861107, HenocTynHa lca~eropusaquja 1993-1995)

5. DraEa S, LeviC Z. The possible role of prolactin in the immunopathogenesis of multiple sclerosis. (Review) Med Hypotheses 1996; 47: 89-92. (1997: I3~narc.r aalc~op 0,530, lca~eropuja 57/72)

6. DraEa S. Is pregnancy a model how we should control some autoimmune diseases? (Review) Autoimmunity 2002; 35 (5): 307-3 12. (2000: H ~ n a l c ~ Oalc~op 1,204, lca~eropuja 8111 16)

7. DraEa S. Are female sex steroids neuroprotective in experimental stroke? (Review) Med Hypotheses 2009; 73; 105 1-2. (2009: M M ~ ~ K T Oalc~op 1,393, lca~eropuja 64191)

IM50) Panosu 06iassbe~u y HaysHuM saconucma HaquoHanHor s ~ a s a i a

fM52) Pan 06iaarne~ y saconucy HaquoHanHor s ~ a s a i a

1. DraEa S. llope~ebaj aKTaBHocTki b e n ~ j a ( ( ~ P H P O , ~ H H X y6~ua)) H nHxoBor o,qroBopa Ha ~ ~ ~ e p @ e p o ~ y TOKY nporpec~je ManHrHe 6onec~a ( l lpe rne ,q~~ m a a a ~ ) Cpn Apx u e n o ~ J I ~ K 1994; 122 (1-2): 48-50.

1. DraEa S. The effect of adjuvant tamoxifen therapy, compared to the effect of adjuvant chemotherapy, on immunocompetence of patients with "early" breast carcinoma. EOS. J. Immunol1994; 14: 1-5.

2. DraEa S. Estriol and Progesterone: A New Role for Sex Hormones. (Review) Int J Biomed Sci 2006; 2 (4): 100-2.

lM34) Panosu caonruTeHu Ha cIcynoBuMa ~ e f i y ~ a p o n ~ o r s ~ a s a i a WTaMnaHu y U3BOQUMa

1. DraEa S. The effect of adjuvant tamoxifen therapy or adjuvant CMF chemotherapy on immunocompetence of patients with "early" breast carcinoma. 6th EORTC Breast Cancer Working Conference. Amsterdam, September 1994. Eur J Cancer, 30, Suppl2, 1994.

2. Dragin A., StefanoviC A., JoviC S., Svirtlih L., LjeseviC B., MijatoviC S., DraEa S, Vidakovic P., Hrkovic M. Intrahospital rehabilitation treatment outcome of patients suffered the stroke. 2nd World Congress of the International Society of Physical and Rehabilitation Medicine- ISPRM, Prague, 2003.

3. DraEa S. Treatment of low-frequency electromagnetic field: possibility of symptoms improvement in MS patients (Pilot study). 4th World Congress of Neurorehabilitation, Hong Kong, China. Neuroreh Neural Repair 2006; 20 (1): p. 216.

4. DraEa S, Dragin A, StefanoviC A. Immunomodulatory role of pregnancy-associated hormones: an alternative treatment of multiple sclerosis. The 2nd Mediterranean Conference of Neuroscience, Marrakech, Morocco, December 2006.

5. DraEa S, Kolar D. Localization of cerebral ischemia as a factor of post-stroke depression. 1 oth Jubilee Multidisciplinary International Conference of Biological Psychiatry, St. Petersburg, Russia, May 2007.

6. DraEa S. Sex-related difference as a factor of poststroke depression. 1 lth Multidisciplinary Neuroscience and Biopsychiatry Conference "Stress and Behavior" (lSt ISBS Conference), St. Petersburg, Russia, May 2008.

7. DraEa S, Dragin A., StefanoviC A., LjeSeviC B., GavriloviC M., MijatoviC S. A patient with four autoimmune disorders affecting nervous system (Case report). 6th International Symposium on experimental and clinical neurobiology, Kosice, Slovak Republic, September 2008.

8. DraEa S, StefanoviC A, Dragin A, LjeSeviC B, Paspalj D. The role of lateralization in the functional outcome of patients after middle cerebral artery stroke. 41 st European Brain and Behavior Society Meeting, Rhodes Island, Greece, September 2009.

9. DraEa S. Sex differences in first-ever unilateral stroke recovery. One hundred years of Ivan Djaja's Belgrade School of Physiology. International Symposium, Belgrade, September 2010.

1. a p a r u ~ A, C T ~ @ ~ H O B H ~ A, ~ B ~ I ~ T J I M X n , JOB& C, Jbemesuh E, Muja~osuh C, Apasa C. IIpahe~je @ y ~ ~ q a o ~ a n ~ o r onopasKa 60necHuKa ca qepe6posac~ynap~u~ MHCYJITOM TOKOM pexa6anu~aquje. 3. Ko~rpec @usPija~apa Cp6aje a I_lp~e rope, Hrano. 360pH1.1~ panosa 2002, 184.

2. C~e@a~osPih A, Joauh C, a p a r a ~ A, Jberuesuh E,. Apasa C, LUskip~nux JI. nope~ehaj 6ana~ca KOA ~ O ~ ~ C H M K ~ Ca o m ~ e h e b e ~ UHC-a. ~ ~ O P H H K panoaa, 6. Ko~rpec @asaja~apa Cp6uje ki w ~ e rope, H O B ~ M ~ ~ P 2006.

3. J6eLUe~uh E, J O B M ~ C, C T ~ @ ~ H O B H ~ A, Apasa C.. E n l l n e n ~ t i v ~ ~ HananPi HaKOH MexaHuvKor o m ~ e h e ~ a ~ o s r a . 360pHk-i~ panosa, 6. Ko~rpec @usuja~apa Cp6aje ki

U p ~ e rope, H O B ~ M ~ ~ P 2006. 4. JbeIIIe~uh E, Josah C, CTe@a~o~ah A, Apasa C. EET KapaKTepMCTMKe KOA

n a q a j e ~ a ~ a ca lpayMaTcKoM nospenoM ~ o s r a : ~ o ~ n a p a q a j a KOA cy6jeKaTa ca noc-rrpayMaTcKoM enanencajo~ a oco6a 6e3 enunenTuvKux Hanana. 3 6 0 ~ ~ 1 3 ~ panosa, 6. Ko~rpec ausaja~apa Cp6aje a rope, H O B ~ M ~ ~ P 2006.

5. ~ B M ~ T J I M X n , cTe@aH~~kih A,, &U~MH A, J6eUIe~Pih 6,. Apasa C. @ ~ H K ~ M O H ~ ~ H ~ IIpOUeHa oco6a Ca omTehebe~ UeHTpanHor HePBHOr CUCTeMa, ~ ~ O P H B K PaAOBa, 6. Ko~rpec @PisPija~apa Cp6aje uy U p ~ e rope, H O B ~ M ~ ~ P 2006., 139-142.

6. &3arkiH A, CT~@Z~HOBP~~ A, Kabyx x., Sbemesuh E, Apasa C.. @ ~ H K ~ F ~ o H ~ J I H M OnOpaBaK 6 0 n e c ~ t i ~ a nocne MOXnaHOr ynapa. ~ ~ O P H M K panosa, 6. Ko~rpec @asaja~apa Cp6aje a U p ~ e rope, H O B ~ M ~ ~ P 2006.

7. C ~ e @ a ~ o s a h A,, Josuh C, a p a r u ~ A, J6emesah E,. Apasa C, LUBHPTIIUX A. @ y ~ ~ q a o ~ a n ~ a npoqeHa n a q u j e ~ a ~ a nocne MoxAaHor ynapa: nopelje~e Fugl-Meyer npoueHe a TecTa ~ocesaba a xsaTaba napeTavHe pyrce (ARAT). ~ ~ O P H M K panosa, 6. Ko~rpec @usaja~apa Cp6aje a m ~ e rope, H O B ~ M ~ ~ P 2006.

(M71) 0~6pabeHa norcTopcKa nacep~aqaja ccnon~a c n e q a @ a v ~ o c ~ ti qepe6pan~a acu~elpaja Kao @ a ~ ~ o p a OnopasKa naqajesa~a nocne ~epe6po~acKy~1apHor u~3yn~a)) . ( M ~ A U ~ ~ ~ H C K M @aKyIlTeT y Kparyjesqy, 2010. roll., MeHTOP: np0@ Ap 30pkiqa C T ~ B H ~ , 6poj clpaaa: 128)

OA 2006. roA. je snaH y p e b ~ s a s ~ o r o ~ 6 o p a saconuca ((International Journal of Biomedical Science)), ~ ~ ~ J I H K O B ~ H O ~ y C ~ ~ A H ~ ~ H H M A M ~ P H ~ K H M Apxasa~a, www.ijbs.org ( H H A ~ K C H ~ ~ H y Embase, Chemical Abstracts, Index Copernicus) H

p e q e ~ 3 e ~ ~ saconuca "Indian Journal of Medical Sciences", n y 6 n ~ ~ o s a ~ o r y ~ I H A H ~ H , www. indianjmedsci.org ( M H A ~ K C M ~ ~ H y PubMedIIndex Medicus, SCOPUS, SIIC databases, EBSCO Publishing's Electronic Databases).

B p c ~ a H K B ~ H T M @ M K ~ ~ H ~ ~ H ~ J W H O - H C T ~ ~ X H B ~ ~ K H X pe3yn~a~a ~p Cabe Apasa 3a ~ 3 6 0 ~ y 3 ~ a b e HaY9HU C a p a a H U K cy npHKa3aHH y T a 6 e n ~ 1, AOK Cy y T a 6 e n ~ 2 n p ~ ~ a 3 a ~ ~ napaMeTpH KsanmeTa saconma ( y ~ y n ~ ~ m n a m @amop saconma y K O ~ H M

Cy ~ ~ ~ J I M K O B ~ H H ~ ~ A O B H ) . Y K Y ~ H ~ HaJWHa KOMneTeHTHOCT KaHAHAaTa, IIpOH3aLUJIa H3 I I ~ ~ J I H K O B ~ H H X

paAosa, H ~ H O C H 45,4 OA sera ce BHme OA nonoBHHe 6 0 ~ o s a (26) OAHOCH Ha n y 6 n ~ ~ a q ~ j e in extenso y M ~ ~ ~ H ~ P O A H H M saconucma. k13 cnMcKa paAoBa ~p Cabe Apasa n0Tpe6~0 je HCT&H 8 PaAOBa ~ ~ ~ J I H K O B ~ H H X y qeJIMHH y M ~ ~ ~ H ~ P O A H M M 9aCOnMCMMa, OA K O ~ M X je j e ~ a ~ 06jasfie~ y MCTaKHYTOM M ~ ~ ~ H ~ ~ O A H O M saCOnHCy.

4. Caonlumetbe ca ~e@ynapodnoz myna lummnano y us60i)Y (M34) 5. Pad y Yaconucy nnyuonannoz snavaja (M52) 6. Pad y n n y ~ n o ~

B p c ~ a p e 3 y n ~ a ~ a

1. Pad y UCmUKHymOM M ~ @ H U ~ O ~ H O M Yaconucy (M22)

Yaconucy (M23) 3. Ypequsatbe nayYnoz Yaconuca (M28)

n p s u ayTOp

1

rpyna

M20

ducepma yuja (M71)

Koay~op

YICynaH MMnaKT @ ~ K T O P

saconaca y ~ o j a ~ cy I I ~ ~ J I ~ I K O B ~ H P ~ ~ ~ A O B P ~

H a y ~ ~ k i CapaAHkIK

B p e ~ ~ o c ~ HHQMlcaTOpa M

1 x 5 = 5

Paaosa: I 1 Mssoaa: 16 Y ~ y n ~ o : 45,4 M70 6

n o ~ p e 6 ~ o

1

O c ~ s a p e ~ o

6,027

EJIEMEHTM 3A KBAJIMTATmBHY OUEHY HAmHOT AOIIPMHOCA K A W W A T A

1. IIorcasa~emi ycnexa y naysnoiv pany

Cmune~duje Opza~u3ayuo~ux KoMumema 3a yyeultze Ha ~ e @ y ~ a p o d ~ m z c ~ y n o e u ~ a

1. C e n ~ e ~ 6 a p 1994: C ~ a n e ~ n a j a O p r a ~ a s a q a o ~ o r KoMaTeTa 3a y~eruhe Ha 6th EORTC Breast Cancer Working Conference, Amsterdam, the Netherlands

2. Qe6pyap 2006: C ~ a n e ~ n a j a O p r a ~ a s a q a o ~ o r KoMaTeTa 3a y~eruhe Ha 4th World Congress of Neurorehabilitation, Hong Kong, China

3. Aeqe~6ap 2006: C ~ a n e ~ n a j a O p r a ~ a s a q a o ~ o r KoMaTeTa 3a y~eruhe Ha 2nd Mediterranean Conference of Neuroscience,. Marrakech, Morocco

4. C e n ~ e ~ G a p 2008: C ~ a n e ~ n a j a Opra~asaquo~or KoMuTeTa 3a y~eruhe Ha 6th International Symposium on experimental and clinical neurobiology, Kosice, Slovakia.

5. C e n ~ e ~ 6 a p 2009: C ~ a n e ~ n a j a O p r a ~ a s a q a o ~ o r KoMaTeTa 3a y~eruhe Ha ~ o ~ @ e p e ~ q a j a : European Brain and Behaviour Society Meeting.. Rhodes Island, Greece

6. C e n ~ e ~ 6 a p 2009: C ~ a n e ~ n a j a O p r a ~ a s a q a o ~ o r KoMa-re-ra 3a y~eruhe Ha OM1 Salzburg Medical Seminars ((Rehabilitation Medicine)), Salzburg, Austria

Yna~cmeo y c m p y ~ ~ m z u HayYHmz dpyulmemza Y n a ~ je Cpnc~or neKapcKor npyru-rsa, Apyru~sa 3a HeypoHayKe CpGaje, The

European Federation of Neurological Societies, S I e ~ a p c ~ e KoMope Cp6aje.

Yna~cmeo y ype@ueav~mz od6opmza ~ e @ y ~ a p o d ~ u x yaconuca I I o ~ a 3 a ~ e ~ b ycnexa y HayYHoM pany a a@ap~aqaje ac-cpaxasaBa np C a ~ e

Apava je na je on 2006. ron. YnaH ypeljasau~or 0~60pa Yaconaca ((International Journal of Biomedical Science)), n y 6 n a ~ o s a ~ o r y C j e n a B e ~ a ~ A M ~ ~ H Y K H M m x a s a ~ a , a p e s e ~ 3 e ~ ~ Yaconaca "Indian Journal of Medical Sciences", n y 6 n u ~ o s a ~ o r y I4~naj1jl.1.

2. A ~ r a x o s a n o c ~ y pa3soiv vcnosa 3a Haysnu pan, 06pa30sa~y u c b o p ~ u p a ~ y naysnux rcanposa

Iledazoul~u pad IIenaroru~a pan np C a ~ e Apava je sesaa 3a eny~aqajy c-ryneHa-ra a

cneqaja~1a3a~a~a a3 @ H ~ B K ~ J I H ~ MenaqaHe a pexa6ma~aqaje y 06na~~1.r ~eypopexa6ana~asaje Ha K n a ~ a q a 3a pexa6l .m~~aq~jy ((Ap M.~oToBH~)).

Ymuyaj~ocm ~ a y ~ ~ u x padoea (6poj y umama) I I p e ~ a 6a3a SCOPUS on 1996.-2010. ron. panosa ~p C a ~ e Apaua,

~ Y ~ J I H K O B ~ H F ~ Y M ~ ~ ~ H E ~ ~ o A H F ~ M YaCOnHCHMa, Cy IJHTHpEiHFi 49 IIYTEi Y M ~ ~ ~ H ~ ~ o A H F ~ M

raconMcma, on ~ o j u x cy 3 ayToquTaTa. Ta~or)e, panosu cy quTqaHu u y M ~ ~ ) ~ H ~ P O ~ H H M u 3 n a ~ u ~ a m u r a u y46eHkiKa u AOKTOPCKHM nucep~aquja~a.

Panosu ((Prolactin as an immunoreactive agent (Review)" u "The possible role of prolactin in the immunopathogenesis of multiple sclerosis. (Review) u ~ a j y ~a j sehu 6poj qma-ra: 22, O ~ H O C H O 16 quTaTa.

Pan: DraEa S. Is pregnancy a model how we should control some autoimmune diseases? (Review) Autoimmunity 2002; 35 (5): 307-3 12. qu~upajy:

H a c n o ~ A ~ T o ~ TOG Y ~ C O ~ H C qliTaTli 1. Multiple sclerosis and Albrecht,P.Fischer,20 10 BMC Research Notes 3, 0 pregnancy: What does the patient D., Moser, A. art. no. 9 1 think? a questionnaire study 2. Are female sex steroids DraEa, S. 2009 Medical Hypotheses 73 0 neuroprotective in experimental (6), pp. 105 1-1052 stroke 3. Synthetic oligopeptides related Van Rogier Den 2009 Shock 3 1 (3), pp. 285- 5 to the f2-subunit of human Berg, H., Khan, 291 chorionic gonadotropin attenuate N.A., Van Zee, inflammation and liver damage M.D., Bonthuis, after (Trauma) hemorrhagic shock F., Ijzermans, and resuscitation J.N.M., Dik, W.A., 4. The ThllTh2 paradigm: Still Chaouat, G. 2007 Seminars in 40 important in pregnancy? Immunopathology 29

(2), pp. 95-1 13 5. Immunity in the normal Cardoso Pereira, 2005 Revista Brasileira de I pregnancy and in the patient with A., Ramires De Reumatologia 45 (3), systemic lupus erythematosus Jesas IV., pp. 134-140 (SLE) Verderame Lage,

L., Abramino R. 6. Modifications of immune Berthelot, J.-M. 2005 Revue du Rhumatisme 2 response during pregnancy: (Edition Francaise) 72 Implications in rheumatoid (8), pp. 686-694 arthritis and systemic lupus 7. Pregnancy and Inflammatory Perdriger, A. 2005 Revue du Rhumatisme 0 Arthritis (Edition Francaise) 72

1 (8), pp. 739-743 8. The environment and Prummel, M.F., 2004 European Journal of 80 autoimmune thyroid diseases Strieder, T., Endocrinology 150 (5),

Wiersinga, W .M. pp. 605-618 9. Tissue repair in rheumatoid Hart, D.A., Kydd, 2004 Best Practice and 5 arthritis: Challenges and A.S., Frank, C.B., Research: Clinical opportunities in the face of a Hildebrand, K.A. Rheumatology 18 (2), systemic inflammatory disease pp. 187-202 10. AOKTOPCK~ nucep~aquja: Albrecht P 2007 Universitat zu Liibeck Familienplanung und

Krankheitsverlauf in der Schwangerschaft von Multiple Sltlerose Patientinnen 1 1 .K&~ra: Multiple sclerosis Olek. MJ. Ed. 2005 Humana Press Etiology, Diagnosis, and New Treatment Strategies

Pan: DraEa S, LeviC Z. The posible role of prolactin in the immunopathogenesis of multiple sclerosis. (Review) Med Hypotheses 1996; 47: 89-92. uk~~k~pajy:

Hacno~ AYTOP roa Yaconuc ~ H T ~ T H

1. Inflammatory bowel Kwan, L.Y., 20 10 Expert Review of 1 disease and pregnancy: An Mahadevan, U. Clinical Immunology 6 update (4), pp. 643-657 2. A population-based study Moffatt, D.C., 2009 American Journal of 3 of breastfeeding in Ilnyckyj, A., Gastroenterology 104 inflammatory bowel Bernstein, C.N. (1 0), pp. 25 17-2523 disease: Initiation, duration, and effect on disease in the postpartum period 3. Inflammatory bowel Siegmund, B., Zeitz, 2009 Zeitschrift fur 1 disease and pregnancy M. - Gastroenterologie 47

(lo), pp. 1069-1074 4. Management of the Dubinsky, M., 2008 Inflammatory Bowel 9 pregnant IBD patient Abraham, B., Diseases 14 (12), pp.

Mahadevan, U. 1736-1750 5. Hormonal influences in Shuster, E.A. 2008 Current Topics in 5 multiple sclerosis

6. White matter plasticity Gregg C., Shikar V., and enhanced remyelinationLarsen P., Mak, G., in the maternal ClVS Chojnacki, A., Yong,

VW., Weiss, S. 7. Serum prolactin level in Shafa, M.A., multiple sclerosis patients Vakilian, A.,

Poorebrahimi, A., Kahnali, J.A.

8. Serum prolactin level in Harirchian, M.H., patients with multiple Sahraian, M.A., sclerosis: A case control Shirani, A. study 9. The role of breastfeeding Kane, S., Lemieux, in postpartum disease N. activity in women with inflammatory bowel disease

~icrobio1o-g~ and Immunology 3 18, pp. 267-3 1 1

2007 Journal of Neuroscience 39 27 (8), pp. 18 12-1 823

2006 Journal of Research in 0 Medical Sciences 11 ( 9 , pp. 325-328

2006 Medical Science 8 Monitor 12 (4), pp. CRI 77-CR180

2005 American Journal of 22 Gastroenterology 100 (I), pp. 102-105

10. Effectiveness of Walker, S.E. bromocriptine in the treatment of autoimmune diseases 1 1. Is pregnancy a model DraEa, S. how we should control some autoimmune diseases? 12. Prolactin stimulation in Heesen, C., Gold, multiple sclerosis - An S.M., Bruhn, M., indicator of disease ~ A n c h , A., Schulz, subtypes and activity? K.-H. 13. Prolactin in patients Moszkorzova, L., with systemic lupus Lacinova, Z., erythematosus Musilova, L., Marek,

J., Dosta, C. 14. Estrogen, prolactin, and McMurray, R.W. autoimmunity: Actions and interactions 15. Roles of prolactin and Walker, S.E., gonadotropin-releasing Jacobson, J.D. hormone in rheumatic diseases 16. Pregnancy ameliorates Agarwal, R.K., Chan, induction and expression ofC.-C., Wiggert, B., experimental autoimmune Caspi, R.R. uveitis 17. Kmra : Hormonal Rodriguez M. Influences in Multiple Sclerosis

2002 NeuroImmune Biology 0 2 (C), pp. 287-296

2002 Autoimmunity 35 (5), 9 pp. 307-312

2002 Endocrine Research 28 7 (1 -2), pp. 9- 1 8

2001 Ceska Revmatologie 9 0 (3), pp. 145-149

2001 International 7 9 Immunopharmacology 1 (6), pp. 995-1008

2000 Rheumatic Disease 5 4 Clinics of North America 26 (4), pp. 7 13-736

1999 Journal of Immunology 30 162 (5), pp. 2648-2654

2008 Springer Berlin Heidelberg

Pan: DraEa S. Prolactin as an immunoreactive agent (Review). Immunol Cell Biol 1995; 73: 481- 483. u ~ ~ ~ p a j y :

Hacno~ AYTOP ro,q Yaconuc y u ~ a ~ u 1. Sublingual allergen O'Hehir, R.E., 2007 Current Medicinal 10 immunotherapy : Sandrini, A., Chemistry 14 (21), Immunological mechanisms Anderson, G.P., pp. 2235-2244 and prospects for refined Rolland, J.M. vaccine preparations 2. Prolactin is involved in mderscheim, 2007 Neuroscience 145 (3), 10 glial responses following a TAE., Gorba, T., pp. 963-973 focal injury to the juvenile ratpathipati, P., Kokay brain I.C, Grattan DR.,

Williams CE et a1

3. Sublingual Leatherman, B.D., 2007 Otolaryngology - Immunotherapy: Past, Owen, S., Parker, Head and Neck present, paradigm for the M., Chadwick, S., Surgery 136 (3 future? A review of the Fornadley, J.A., SUPPI;.), pp. S 1 -S20 literature Colson, D., Fass, P.

4. Cutting edge: Lupus Peeva, E., 2006 Journal of susceptibility interval Sle315 Gonzalez, J., Hicks, Immunology 177 (3), confers responsiveness to R., Diamond, B. pp. 1401-1405 prolactin in C57BLl6 mice 5. Psychological stress affectsIppoliti, F., De 2006 Pediatric Allergy and response to sublingual Santis, W., Immunology 17 (5), immunotherapy in asthmatic Volterrani, A., pp. 337-345 children allergic to house Canitano, N., dust mite Frattolillo, D.,

Lucarelli, S., et al. 6. The role of vasopressin in Zelena, D., Mergl, 2006 Brain Research diabetes mellitus-induced Z., Makara, G.B. Bulletin 69 (I), pp. hypothalamo-pituitary- 48-56 adrenal axis activation: Studies in Brattleboro rats 7. Hypophysectomy and Campos-Rodriguez, 2006 Infection and neurointermediate pituitary R., Quintanar- Immunity 74 (3), pp. lobectomy reduce serum Stephano, A., 1883-1889 immunoglobulin M (IgM) Jarillo-Luna, R.A., and IgG and intestinal IgA liver-~~uillAn, responses to Salmonella G., Ventura-Jurez, enterica serovar typhimurium J., Rivera-Aguilar, infection in rats V., Berczi, I., et al. 8. Prolactin as a modulator ofPeeva, E., 2004 Biomedicine and B cell fbnction: Implications Venkatesh, J., Pharmacotherapy 5 8 for SLE Michael, D., (5), pp. 310-319

Diamond, B. 9. Decidualization of the Dunn, C.L., Kelly, 2003 Reproductive human endometrial stromal R.W., Critchley, BioMedicine Online 7 cell: An enigmatic H.O.D. (2), pp. 151-161 transformation 10. Endocrine and Ellingsen, D.G., 2003 Scandinavian Journal immunologic markers in Haug, E., Gaarder, of Work, manganese alloy production P.I., Bast-Pettersen, Environment and workers R., Thomassen, Y. Health 29 (3), pp.

230-238 1 1. Immunomodulation Ippoliti, F., De 2003 Pediatric Allergy and during sublingual therapy in Santis, W., Immunology 14 (3), allergic children Volterrani, A., Lenti pp. 216-221

L., Canitano, N., Lucarelli, S., et a1

12. Prolactin receptor Wallaschofski, H., 2003 Hormone and signaling during platelet Kobsar, A., Koksch, Metabolic Research activation M., Siegemund, A., 35 (4), pp. 228-235

Hentschel, B., Tuschy, U. et al.

13. Expression of nuclear Kojima, H., Tamura 2003 American Journal of factor of activated to cells T., Okuda, T., Kato Reproductive mRNA in maternal peripheralc., Kinosita Y., Immunology 49 (3), blood cells Honjo, H. pp. 139-148 14. Is pregnancy a model Draea, S. 2002 Autoimmunity 35 (5), 9 how we should control some pp. 307-3 12 autoimmune diseases? 15. Parvovirus B 19 Mitchell, L.A. 2002 Journal of Medical 24 nonstructural (NS 1) protein Virology 67 (2), pp. as a transactivator of 267-274 interleukin-6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections? 16. Prolactin receptor in Martinez, L.B., 2002 Acta Obstetricia et human endometriotic tissues Leyva, M.Z., Gynecologica

Romero, I.C. Scandinavica 81 (I), pp. 5-10

17. Bromocriptine restores Peeva, E., Grimaldi, 2000 Journal of Clinical 55 tolerance in estrogen-treated C., Spatz, L., Investigation 106 mice Diamond, B. (1 I), pp. 1373-1379 18. Clinical features and IgG Onouchi, H., Muro, 1999 Journal of 7 subclass distribution of anti- Y., Tomita, Y. Autoimmunity 13 (2), p80 coilin antibodies pp. 225-232 19. Localization and temporalJones, R.L., 1998 Journal of Clinical 42 expression of prolactin Critchley, H.O.D., Endocrinology and receptor in human Brooks, J., Jabbour, Metabolism 83 (I), endometrium H.N., Mcneilly, A. pp. 258-262 20. Lactation increases Feng, J.-C., Loh, T.- 1998 Life Sciences 63 (2), 10 prolactin receptor expression T., Sheng, H.-P. pp. 111-119 in spleen and thymus of rats 21. Synthesis and Morganti, L., 1998 Biotechnology and 11 characterization of Scares, C.R.J., Applied Biochemistry recombinant, authentic Affonso, R., Gout, 27 (I), pp. 63-70 human prolactin secreted into P.W., Bartolini, P. the periplasmic space of Escherichia coli 22. Prolactin modulation of Meli, R., Mattace 1997 Life Sciences 61 (14), 29 nitric oxide and TNF Raso, G., Gualillo, pp. 1395-1403 production by peripheral O., Pacilio, M., Di neutrophils in rats Carlo, R.

23. ~ O K T O P C K ~ nucep~auuja: Fafiler PF 2000 Justus-Liebig- Der einfluss serotonerger Universitat Giefien stimulation auf die migration peripherer leukozyten unter berucksichtigung der potenzuellen mediatorrolle von prolaktin 24. DOKTOPCK~ nacep~asuia: Bromfield JJ 2006 University of The physiological Adelaide, Australia significance of insemination in programming pregnancy outcome

Pas: DraEa S. Endocrine-immunological homeostasis: the interrelationship between the immune system and sex steroids involves the hypotalamic-pituitary-gonadal axis. (Review) Panminerva Med 1995; 37(2): 71-6. su~apajy:

Hacno~ AYTOP 1. Morphological changes in Bobyntsev, I.I., immune and endocrine Dolzhikov, A.A., organs of mice injected with Sever'yanova, L.A. a gonadotropin-releasing hormone analog 2. Effects of flavonoids fromQin, D.-N., She, B.- Semen Cuscutae on the R., She, Y.-C., reproductive system in male Wang, J.-H. rats 3. Krmra: Handbook of Cacioppo JT, psyhophysiology Tassinary LG,

Bernston GG (Eds). 4. K ~ u r a : Exploring the Wizemann TM, biological contributions to Pardue ML human health: does sex matter? 5. Ksura: Seasonal patterns Nelson RJ. of stress, immune function, and disease

rag Yacon~c I ] [ u ~ a ~ u 2005 Bulletin of 0

Experimental Biology and Medicine 139 (I), pp. 101-104

2000 Asian Journal of 9 Andrology 2 (2), pp. 99-1 02

2000 CAMBRIDGE UNIVERSITY PRESS

200 1 NATIONAL ACADEMY PRESS, Washington, USA

2002 CAMBRIDGE UNIVERSITY PRESS

Pas DraEa S. Possible role and mechanism of inactivation of decidual NK cells in pregnancy. (Review) Med Hypotheses 1994; 43: 418-9. sa~upajy:

Hacno~ AYTOP roa Yaconuc UUT~TA 1. Novel hyperactive Langer, N., 1999 American Journal of 10 mitogen to endothelial Beach, D., Reproductive cells: Human decidual Lindenbaum, E.S. Immunology 42 ( 9 , pp. NKG5 263-272

E@e~musnu 6poj pabosa

Ap Cafia Apasa je 06jasuna 28 panosa, ymyryjyhu u AOKTOPCK~ nucep~auujy. 11 panosa je n y 6 n u ~ o s a ~ o y uenuau, a 16 je I I ~ ~ ~ ~ K O B ~ H O y ussony. On Hasenemix panosa 8 je n y 6 n u ~ o s a ~ o y ~ e r ) y ~ a p o g ~ u ~ saconucuMa uHneKcupaHuM y Science Citation Index-y .

B e h u ~ a panosa ny6nu~osa~ux y uenuHu y saconucuMa ~ e r ) y ~ a p o n ~ o r u ~ a q u o ~ a n ~ o r s ~ a s a j a cy ~ e o p u j c ~ u panosu, OAHOCHO npernemu rnaHqki (9111).

Cmenen cmocmannocmu y peanu3a yuju pabosa

a p Cafia Apasa je y IIOTlTyHOCTti CaMOCTaJIHa y OCTBapHBafiy klCTpaXkiBafia npkiKa3aHux y npunoxeHkiM panosuMa Y npunor ToMe rosopu u sufieHusa na je np Cafia Apara npsu ayTop csux panosa, OAHOCHO jenki~u ayTop s e b u ~ e panosa (9111) ny6nu~osa~ux y senmu y saconucki~a ~ e r ) y ~ a p o n ~ o r u ~ a q u o ~ a n ~ o r s~ara ja .

3 n a ~ aj pabosa

npernen 06jashe~ux panosa no~a3yje naje ~ a y s ~ o - u c ~ p a x k i s a r ~ k i pan np Cafie Apasa 06y~~aTki0 ucTpaxusafia 1.13 skirue o6nac~u. ny6nki~aqkije ce Mory cspcTaTu y ~ a ~ e r o p u j e npernemu snaHaK u opuruHanaH HaysHu pan us yxux ucTpaxusaseux 06nac.r~: ~ e y p o e ~ ~ o ~ p u ~ o - k i ~ y ~ o n o r u j e , ~eyponoruje u ~eypopexa6unu~aquje.

Y B ~ ~ M H P ~ panosa ny6nu~osa~ux y senmu y saconucuMa ~ e r ) y ~ a p o n ~ o r u HaquoHanHor s ~ a r a j a np Cafia Apara ce 6asu u s y s a s a ~ e ~ cnoxeaux ki~Tepa~quja M3~et)y HeyPo-eHJ(0KpHHOr Pi kiMYHCKOr CUCTeMa: - uMyHoMonynaTopHe ynore nojenua~x xopMoHa (non~ki c~epounu, nponamu~), - s ~ a s a j a k i ~ y ~ o ~ o n y n a s u j e y @ ~ S U O ~ O U I K M M CTafiuMa ( ~ p y ~ ~ o b a , namaquja), - ~ o r y h e ynore nojenki~ux xopMoHa y u ~ y ~ o n a ~ o r e ~ e s k i nojenki~ux 06ohefia (nponamu~ u MynTkinna ceneposa), - @ H ~ ~ . I O ~ O L U K U M CTafiHMa (Tpyn~oha) KaO MOfleJIllMa XOpMOHCKe ~ 0 J ( y n a q ~ j e ayTOllMYHCKkiX ~ O J I ~ C T U , - HeypOIIpOTeKTkiBHe YnOre I I o ~ ~ ~ M H ~ x XOpMOHa (>K~HCKU IIOnHkI CT~POUAU) y eKCnepkIMeHTaJIHuM MOAenllMa uepe6panae M C X ~ M M ~ ~ .

y Deny panosa np Cafia Apara ce 6asu usysasafie~ @ a ~ ~ o p a ( n o n ~ a c n e q u @ ~ r ~ o c ~ u noeanusaq~ja nesuje) ~o jw y a s y Ha npoqec MoTopHor OnopaBKa a kicnohasafie nocTanonnemkirHe nenpecusHocTH KOA naqujeaa~a ca o r u ~ e h e f i e ~ UeHTPmHOr HePBHOr CMCTeMa.

Aeo panosa je 1.13 o6nac~a oaeonoruje. Y AOKTOPCKO~ nucep~aqkijki np Cafia Apara naje HaysHki nonpki~oc carneaasafiy

YnOre eKCIIepPiMeHTaJIHuM Pi KnkiHWsKMM ~ T y ~ k i j a ~ a seh yTeMeJbeHOr KOHqenTa lTOnHHX panma, Kao a KoHqenTa na~epanwsaquje ~ j . acu~eqki je MoxnaHux CTpyK-rypa y KoMnneKcHoM nposecy MoTopHor B ( P Y H K ~ U O H ~ ~ H O ~ OnopasKa naskijesa~a nocne qepe6posac~ynap~or a ~ s y n ~ a .

a p cq MeA Catba a p a ~ a je, Ha OCHOBY npunoxeaux pesyn~a~a, Aana s ~ a ~ a j a ~ AOnpkIHOC KaKO y o6nac~k1 G ~ ~ I Y H M X , TaKO kl KJIklHklYKklX kICTpaXklBatba k13 YXMX

MCTPsUrCkIBaYKkIX 06na~Tkl H ~ Y P O ~ H ~ O K P U H O - U M Y H O ~ O ~ ~ I ~ ~ , ~eypOJI0I'kije kI

~ e y p o p e x a G ~ n ~ ~ a s ~ j e , M a @ ~ p ~ k ~ c a n a ce y C T P ~ H O ~ M H ~ Y Y H O ~ ~ ~ B H O C T H 143 O ~ J I ~ C T M

HeypoHayKa. Ha OCHOBY KBankITeTa 06jaBJbeHkI~ PaAOBa, tbkIXOBe qkITkIPaHOCTkI M C ~ O C O ~ H O C T ~ I

KaHAkIAaTa, cMaTpaMo Aa ~p Catba a p a ~ a Mcnytbasa cse ycnose npe~sk~l j e~e ~ ~ K O H O M o H ~ ~ Y Y H O - M C T ~ ~ X H B ~ Y K O ~ AenaTHocTkl (CnyX6e~ki rnacHm Peny6nkIKe Cp6~je 6p. 110105 i 50106- kIcnpa~Ka) kI npa~kIJIHklK0~ 0 nOCTYnKY HaYkIHa BpeAHOBatba kI KBaHTMTaTklBHOr MCKa3kIBatba HayYHO-MCTPaXMBaYKkIX 3Batba kICTpaXklBaYa (Cnyx6eHkI I'JIaCHMK Peny6nkiKe C p 6 ~ j e 6p.38108) 3a 14360~ y 3satbe Hay=iHH capaaHuK.

C T O ~ ~ , Ca 3aAOBOJbCTBOM npeAJIaXeM0 H ~ Y Y H O M sehy ~ H C T M T Y T ~ 38

MYJITkIAkICqkInJIkIHapHa MCTpaXMBatba Aa YTBPAkI kICnYtbeHOCT YCJIOBa KaHAMAaTa AP Catbe a p a ~ a 3a ~ 3 6 0 ~ y HaseAeHo ssatbe.

YJIAHOBM KOMMCMJE